SCHEMBL4775813

SCHEMBL4775813

Cc1c(CC=N)sc2ccccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 1/20 0.42
GPR3 P46089 1/20 0.41
TAS1R3 Q7RTX0 1/20 0.39
TAS1R1 Q7RTX1 1/20 0.39
ALDH1A1 P00352 1/20 0.38
PRNP P04156 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
HSD11B1 P28845 1/20 0.37
TUBB4A P04350 1/20 0.36
TUBB P07437 1/20 0.36
TUBA3C P0DPH7 1/20 0.36
TUBA1B P68363 1/20 0.36
TUBA4A P68366 1/20 0.36
TUBB4B P68371 1/20 0.36
TUBB3 Q13509 1/20 0.36
TUBB2A Q13885 1/20 0.36
TUBB8 Q3ZCM7 1/20 0.36
TUBA3E Q6PEY2 1/20 0.36
TUBA1A Q71U36 1/20 0.36
TUBA1C Q9BQE3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6118386 0.84 ALDH1A1 (0.41) LOXL2GPR3TAS1R3TAS1R1ALDH1A1
SCHEMBL7984828 0.80 TAS1R3 (0.41) LOXL2GPR3TAS1R3TAS1R1ALDH1A1
SCHEMBL2388976 0.79 CNR2 (0.46) LOXL2GPR3TAS1R3TAS1R1ALDH1A1
SCHEMBL1035524 0.77 LOXL2 (0.48) LOXL2GPR3TAS1R3TAS1R1ALDH1A1
SCHEMBL2702753 0.77 LOXL2 (0.63) LOXL2GPR3TAS1R3TAS1R1ALDH1A1
SCHEMBL719251 0.77 GPR3 (0.44) LOXL2GPR3TAS1R3TAS1R1ALDH1A1
SCHEMBL586085 0.77 GPR3 (0.44) LOXL2GPR3TAS1R3TAS1R1ALDH1A1
SCHEMBL2387916 0.76 CNR2 (0.49) LOXL2GPR3TAS1R3TAS1R1ALDH1A1
SCHEMBL13328626 0.74 CNR1 (0.50) LOXL2GPR3TAS1R3TAS1R1ALDH1A1
SCHEMBL7100115 0.74 LOXL2 (0.42) LOXL2GPR3TAS1R3TAS1R1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1973902-A2 3-HETEROCYCLYLACRYLAMIDE COMPOUNDS AS FABI INHIBITORS AND ANTIBACTERIAL AGENTS Affinium Pharmaceuticals, Inc. (CA) 2008-10-01 EP disclosed
WO-2007067416-A2 HETEROCYCLYLACRYLAMIDE COMPOUNDS AS FABI INHIBITORS AND ANTIBACTERIAL AGENTS AFFINIUM PHARMACEUTICALS, INC. (CA) 2007-06-14 WO disclosed